share_log

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors

DowjonesNews MarketWatch ·  Nov 24, 2021 16:52

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Quest Diagnostics Inc. (DGX) slipped 1.01% to $149.52 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.23% to 4,701.46 and the Dow Jones Industrial Average falling 0.03% to 35,804.38. The stock's fall snapped a three-day winning streak. Quest Diagnostics Inc. closed $11.04 below its 52-week high ($160.56), which the company reached on September 9th.

The stock underperformed when compared to some of its competitors Wednesday, as Laboratory Corp. of America Holdings (LH) fell 0.76% to $283.73, Qiagen N.V. (QGEN) fell 0.53% to $54.56, and Sonic Healthcare Ltd. ADR fell 0.20% to $29.83. Trading volume (719,297) remained 602,449 below its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 24, 2021.

-MarketWatch Automation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment